![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy of PI monotherapy versus triple therapy for 2202 patients in 12 randomised trials
|
|
|
Reported by Jules Levin
HIV Drug Therapy Conference, Glasgow, UK, November 2014
1Jose Arribas, idiPAZ, Hospital La Paz, Madrid, Spain 2. Pierre-Marie Girard, Hopital Saint-Antoine, Paris, France 3. Nicholas Paton, MRC Clinical Trials Unit, London, UK 4. Alan Winston, St Mary's Hospital, London, UK 5. Anne-Genevieve Marcelin, Hopital Pitie Salpetriere, Virology, Paris, France 6. Daniel Elbirt, Kaplan Medical Centre, AIDS Centre, Rehovot, Israel 7. Andrew Hill, Liverpool University, UK 8. Maria Blanca Hadacek, Janssen EMEA, Issy-les_Moulineaux, France
![AASLD1.gif](../images/111214/111214-16/AASLD1.gif)
![AASLD2.gif](../images/111214/111214-16/AASLD2.gif)
![AASLD3.gif](../images/111214/111214-16/AASLD3.gif)
![AASLD4.gif](../images/111214/111214-16/AASLD4.gif)
![AASLD5.gif](../images/111214/111214-16/AASLD5.gif)
![AASLD6.gif](../images/111214/111214-16/AASLD6.gif)
![AASLD7.gif](../images/111214/111214-16/AASLD7.gif)
![AASLD8.gif](../images/111214/111214-16/AASLD8.gif)
![AASLD9.gif](../images/111214/111214-16/AASLD9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|